This directory contains the synthetic version of the real-world benchmark `Lung Cancer` describing the medical characteristics of the lung cancer patients. The characteristics includes, ***prescribed drug (e.g., Afatinib), cancer mutation (e.g., ALK Negative), smoking habit (e.g., Current Smoker), cancer stage (e.g., IVB) and relapse event occurence***. We anonymized patients' sensitive information. If you use this benchmark please cite it as
> Calvo Virginia, Niazmand Emetis, Carcereny Enric, Rodriguez-Abreu Delvys, Cobo Manuel, López-Castro Rafael, Guirado María, Camps Carlos, Laura Ortega
Ana, Bernabé Reyes, Massutí Bartomeu, Garcia-Campelo Rosario, del Barco Edel, Luis González-Larriba José, Bosch-Barrera Joaquim, Martínez Marta, Torrente
María, Vidal María-Esther, and Provencio Mariano. 2024. Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role
of genetic risk. Lung Cancer (2024). https://doi.org/10.1016/j.lungcan.2024.107920
```
@article{Calvo24,
    author = {Calvo Virginia and 
              Niazmand Emetis and
              Carcereny Enric and
              Rodriguez-Abreu Delvys and
Cobo Manuel and 
López-Castro Rafael and
 Guirado María and
Camps Carlos and
Laura Ortega Ana and
Bernabé Reyes and
Massutí Bartomeu and
Garcia-Campelo Rosario and
del Barco Edel and
Luis González-Larriba José and
Bosch-Barrera Joaquim and
Martínez Marta and
Torrente María and
Vidal María-Esther and
Provencio Mariano},
    title = {Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk},
    journal = {Lung Cancer},
    year = {2024},
    doi = {10.1016/j.lungcan.2024.107920}
}
```
